HCA Healthcare, Inc. $HCA Stock Holdings Boosted by UniSuper Management Pty Ltd

UniSuper Management Pty Ltd raised its position in shares of HCA Healthcare, Inc. (NYSE:HCA) by 4.9% in the third quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 76,373 shares of the company’s stock after purchasing an additional 3,537 shares during the period. UniSuper Management Pty Ltd’s holdings in HCA Healthcare were worth $32,550,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also made changes to their positions in HCA. Norges Bank bought a new stake in HCA Healthcare during the 2nd quarter valued at $1,152,408,000. Viking Global Investors LP lifted its holdings in HCA Healthcare by 58.5% in the second quarter. Viking Global Investors LP now owns 1,872,133 shares of the company’s stock worth $717,214,000 after purchasing an additional 690,773 shares during the period. Nordea Investment Management AB increased its stake in HCA Healthcare by 5.2% during the 3rd quarter. Nordea Investment Management AB now owns 975,741 shares of the company’s stock valued at $415,656,000 after buying an additional 47,960 shares during the period. Pacer Advisors Inc. lifted its stake in shares of HCA Healthcare by 6,115.3% in the 3rd quarter. Pacer Advisors Inc. now owns 911,096 shares of the company’s stock worth $388,309,000 after acquiring an additional 896,437 shares during the period. Finally, LSV Asset Management increased its stake in shares of HCA Healthcare by 0.4% during the second quarter. LSV Asset Management now owns 868,849 shares of the company’s stock valued at $332,856,000 after acquiring an additional 3,396 shares during the period. 62.73% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

HCA has been the subject of a number of research reports. Leerink Partners increased their price target on HCA Healthcare from $470.00 to $507.00 and gave the company an “outperform” rating in a research note on Thursday, January 15th. Wall Street Zen upgraded shares of HCA Healthcare from a “buy” rating to a “strong-buy” rating in a research report on Saturday, October 25th. Mizuho increased their price target on HCA Healthcare from $505.00 to $520.00 and gave the company an “outperform” rating in a research report on Thursday, December 18th. Truist Financial upped their price objective on shares of HCA Healthcare from $495.00 to $520.00 and gave the company a “buy” rating in a research note on Monday, January 5th. Finally, Weiss Ratings restated a “buy (b)” rating on shares of HCA Healthcare in a report on Monday, December 29th. Fourteen research analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus price target of $488.75.

Insider Activity at HCA Healthcare

In related news, EVP Michael R. Mcalevey sold 3,892 shares of the firm’s stock in a transaction that occurred on Wednesday, November 5th. The stock was sold at an average price of $473.79, for a total value of $1,843,990.68. Following the transaction, the executive vice president directly owned 3,487 shares of the company’s stock, valued at approximately $1,652,105.73. This trade represents a 52.74% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Corporate insiders own 1.30% of the company’s stock.

HCA Healthcare Price Performance

HCA opened at $470.52 on Friday. The business has a 50-day moving average of $480.37 and a 200-day moving average of $433.53. HCA Healthcare, Inc. has a fifty-two week low of $295.00 and a fifty-two week high of $520.00. The company has a market capitalization of $107.37 billion, a PE ratio of 18.19, a price-to-earnings-growth ratio of 1.28 and a beta of 1.36.

HCA Healthcare (NYSE:HCA) last released its quarterly earnings data on Friday, October 24th. The company reported $6.96 earnings per share (EPS) for the quarter, beating the consensus estimate of $5.64 by $1.32. HCA Healthcare had a net margin of 8.53% and a negative return on equity of 792.25%. The business had revenue of $19.16 billion during the quarter, compared to analyst estimates of $18.55 billion. During the same quarter in the previous year, the business earned $4.90 EPS. HCA Healthcare’s quarterly revenue was up 9.6% compared to the same quarter last year. On average, equities research analysts expect that HCA Healthcare, Inc. will post 24.98 earnings per share for the current fiscal year.

HCA Healthcare Profile

HCA Healthcare is a for?profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.